Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05NTY
|
|||
| Former ID |
DIB011453
|
|||
| Drug Name |
NPC-18166
|
|||
| Synonyms |
IDDB8389
Click to Show/Hide
|
|||
| Indication | Psychotic disorder [ICD-11: 6A20-6A25] | Terminated | [1] | |
| Company |
Scios Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | 5-HT 2 receptor (5HT2R) | Target Info | Modulator | [2] |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Gap junction | ||||
| Serotonergic synapse | ||||
| Inflammatory mediator regulation of TRP channels | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004563) | |||
| REF 2 | WO patent application no. 2004,0825,84, 5ht2c receptor antagonists in the treatment of schizophrenia. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.